Output of the European Medicines Agency policy on access to documents related to corporate documents

Similar documents
Decision of the Executive Director

Procedural advice to applicants/marketing authorisation holders on re-examination of CVMP opinions

The European Medicines Agency Code of Good Administrative Behaviour

Questions and Answers (Q&As) on the External Guidance of Policy 0070 on Clinical Data Publication (CDP)

Standard operating procedure

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

General guidance on EFSA procurements

European Medicines Agency decision

Mandate, objectives and rules of procedure

General guidance on EFSA procurements

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

Mandate, objectives and rules of procedure

European Medicines Agency decision

Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

UNMIK REGULATION NO. 2003/32 ON THE PROMULGATION OF A LAW ADOPTED BY THE ASSEMBLY OF KOSOVO ON ACCESS TO OFFICIAL DOCUMENTS

EUROPEAN PARLIAMENT DRAFT OPINION. Committee on Petitions PROVISIONAL. 6 September of the Committee on Petitions

RULES OF PROCEDURE OF THE AS-IF PROGRAMME COMMITTEE FOR DEFENCE RESEARCH

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

Procedure for the review and revision of European Union herbal monographs and European Union list entries

JUDGMENT OF THE GENERAL COURT (Second Chamber) 7 June 2011 (*)

COMMISSION DECISION. of setting up the Strategic Forum for Important Projects of Common European Interest

CMDv/BPG/018. BEST PRACTICE GUIDE for Worksharing. Edition number: 03. Edition date: 16 May Implementation date: 01 January 2010

European Medicines Agency decision

European Medicines Agency decision

European Medicines Agency decision

COMMISSION DECISION. of on establishing the European Regulators Group for Audiovisual Media Services

European Medicines Agency decision

Mandate, objectives and rules of procedure for the Inter- Committee Scientific Advisory Group (SAG) for Oncology

European Medicines Agency decision

Memorandum of understanding on working arrangements

European Medicines Agency decision

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

PUBLIC PRIVATE PARTNERSHIPS ACT

and Article I. PURPOSE

Procedure for the review and revision of European Union herbal monographs and European Union list entries

European Medicines Agency decision

Arrangements to be applied by the Agency for public access to documents (Consolidated Version)

Telekom Austria Group Standard Data Processing Agreement

INVESTIGATION OF ELECTRONIC DATA PROTECTED BY ENCRYPTION ETC DRAFT CODE OF PRACTICE

European Medicines Agency decision

RULES OF PROCEDURE. The Scientific Committees on. Consumer Safety (SCCS) Health and Environmental Risks (SCHER)

European Medicines Agency decision

BERMUDA 2004 : 32 OMBUDSMAN ACT 2004

European Medicines Agency decision

Procedure for the systematic review of European Union herbal monographs and/or European Union list entries and supporting documents

European Medicines Agency decision

PROFESSOR GERALD STEINBERG 1 Ben-Maimon Boulevard, Jerusalem, 92262, Israel Applicant. - and -

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

Parallel Consultations

DECISION OF THE MANAGEMENT BOARD

COMMISSION DECISION. of

EURASIAN ECONOMIC COMMISSION COUNCIL D E C I S I O N. 20 June St. Petersburg

European Medicines Agency Inspections

Official Journal of the European Union L 251/3

European Medicines Agency decision

European Medicines Agency decision

"Body" means a governmental, international or non-profit organisation. ***

9308/16 JT/CSM/nb 1 DG F 2C

(12) Environmental information which is physically held by other bodies on behalf of public authorities should also fall within the scope of this

Title: Handling of Paediatric Art. 45 work sharing procedures by the CMDh Secretariat

ANNEX RELATIONS WITH THE COMPLAINANT REGARDING INFRINGEMENTS OF EU LAW

THE FREEDOM OF INFORMATION ACT, Arrangement of Sections PART I PRELIMINARY

European Medicines Agency decision

GRANT AGREEMENT for an ACTION

Act No. 502 of 23 May 2018

ARTICLE 29 Data Protection Working Party

COMMISSION OPINION. of

OUTCOME OF THE COUNCIL MEETING. 3542nd Council meeting. General Affairs. (Art. 50) Brussels, 22 May 2017 PRESS

S.I. 7 of 2014 PUBLIC PROCUREMENT ACT. (Act No. 33 of 2008) PUBLIC PROCUREMENT REGULATIONS, 2014 ARRANGEMENTS OF REGULATIONS PART 1 - PRELIMINARY

COMPLAINTS AND APPEALS POLICY & PROCEDURE

Official Journal of the European Union L 131/7. COUNCIL DECISION of 14 May 2008 establishing a European Migration Network (2008/381/EC)

European Medicines Agency decision

Terms of Reference and Rules of Procedure Health Products Regulatory Authority

ARTICLE 29 DATA PROTECTION WORKING PARTY

BERMUDA COPYRIGHT TRIBUNAL RULES 2014 BR 11 / 2014

Council Regulation (EC) No 2532/98 (23 November 1998)

German construction contract procedures (VOB) - Part A: General provisions relating to the award of construction contracts

EUROPEAN COMMISSION. Brussels, BY AND REGISTERED MAIL WITH ACKNOWLEDGEMENT OF RECEIPT

Data Protection Bill [HL]

The court may allow a witness to give evidence through a video link or by other

European Medicines Agency decision

Development of a European approach to assess the fire performance of facades

Proposal for a COUNCIL DECISION

Transcription:

09 February 2017 EMA/183710/2016 1 2 Output the European Medicines Agency policy on access to s related to corporate s 3 4 5 6 7 8 9 10 11 12 Introductory remarks Aim the This needs to be read in conjunction with the following s: Regulation (EC) 1049/2001 the European Parliament and the Council 30 May 2001 regarding public access to European Parliament, Council and Commission s. European Medicines Agency policy on access to s (EMA/729522/2016). This, which contains guidance for the application Regulation (EC) 1049/2001 to corporate s held by the EMA, is not legally binding. For any not listed, access will be granted or refused in accordance with the principles outlined in the European Medicines Agency policy on access to s. It should also be noted that EMA has not listed all corporate s that it holds, but rather those for which it has received more requests, as well as the main corporate s which are available on its webpage. Therefore, this should be considered as 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact An agency the European Union European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 a living which will be updated on a continuous basis taking into account further experience, as well as the legal interpretation Regulation (EC) 1049/2001 given by the European Court Justice. For s related to human and veterinary products, please refer to the Output the European Medicines Agency policy on access to s related to medicinal products for human and veterinary use (EMA/127362/2006, Rev. 1). This lists a number types which may be subject to requests for access to s. 1. Procurement related s These types have been classified according to the phase the procurement, as follows: 1.1. Documents in relation to the launch the procurement 1.2. Documents in relation to the submission and opening requests to participate 1.3. Documents in relation to the submission and opening tenders 1.4. Documents in relation to the evaluation tenders 1.5. Documents in relation to the award and signature contract or cancellation It should be noted that access to s and/or information concerning procurement s made by specific parties (candidates and/or tenderers) in the at different stages is regulated by the EMA Financial Regulation, making reference to Title V Financial Regulation (EU, Euratom) 966/2012 and Delegated Regulation (EU) 1268/2012. This refers to the general right access to s made under Regulation (EC) 1049/2001. 2. Conflicts interest declarations 3. SOPs and WINs 4. Corporate s available on the EMA s website EMA/127362/2006 Page 2/15

32 33 34 35 36 Abbreviations CCI Commercial confidential information PPD Protection personal data R Releasable n-r n-releasable EMA/127362/2006 Page 3/15

37. 1. Procurement 38. 1.1 Launch the procurement 39. Pre-information notice (PIN) Published on EMA website Yes t applicable t applicable 40. Justification for using a negotiated n-r before the is launched Art. 4.3. 1 st t applicable 41. R after the is launched Yes t applicable t applicable Yes (PPD) 42. Contract notice Published on EMA website Yes t applicable t applicable 43. 1.2. Submission and opening requests to participate 44. List candidates who submitted a request to n-r until the deadline Art. 4.3. 1 st Art. 4.1. (a) t applicable participate in a restricted or for receipt for tenders has competitive with negotiation or elapsed or until negotiated cancellation the EMA/127362/2006 Page 4/15

45. R after the deadline for receipt for tenders has elapsed or until cancellation the, except for the names natural persons or names firms identifying one or more natural persons Yes t applicable t applicable Yes (PPD) 46. Requests to participate Yes n-r until contract Art. 4.3. 1 st t applicable 47. R after contract signature or cancellation Yes t applicable t applicable Yes (PPD and CCI) 48. Written record the opening requests to n-r before deadline for Art. 4.3. 1 st Art. 4.1 (a) t applicable participate receipt tenders has elapsed or cancellation the EMA/127362/2006 Page 5/15

49. R after deadline for receipt tenders has elapsed or cancellation the Yes t applicable t applicable Yes (PPD) 50. Written record the evaluation requests to n-r contract Art. 4.3. 1 st t applicable participate the 51. R after contract signature or cancellation Yes t applicable t applicable Yes (PPD and CCI) 52. Procurement s (notice, invitation to n-r launch Art. 4.3. 1 st t applicable tender, tender specifications, terms EMA/127362/2006 Page 6/15

53. reference and draft contract) R after launch Yes t applicable t applicable Yes (CCI, including those cases where the exception on confidentiality Art. 153(1) the rules implementation the Financial Regulation applies) 54. Additional information, questions & answers n-r publication information or information made available to candidates or tenderers Art. 4.3. 1 st Unfair treatment tenderers t applicable EMA/127362/2006 Page 7/15

55. R from publication or information made available to candidates or tenderers Yes t applicable t applicable Yes (CCI, including those cases where the exception on confidentiality Art. 153(1) the rules implementation the Financial Regulation applies) 56. 1.3. Submission and opening tenders 57. Received tenders Yes n-r contract signature Art. 4.3. 1 st Art. 4.2. 1 st indent t applicable 58. n-r after contract Art. 4.2. 1 st Art. 4.1 (a) t applicable signature indent 59. Decision appointing the committees for the n-r contract Art. 4.3. 1 st Art. 4.2. 1 st t applicable opening and evaluation tenders indent EMA/127362/2006 Page 8/15

60. R after contract signature or cancellation Yes t applicable t applicable Yes (PPD, including the names the members the committee) 61. Written record the opening tenders R Yes t applicable t applicable Yes (PPD) 62. 1.4. Evaluation tenders 63. Declarations on the absence conflicts interest and confidentiality signed by the evaluators R Yes t applicable t applicable Yes (PPD, including names the members the committee) EMA/127362/2006 Page 9/15

64. Clarification requested from tenderers during Yes n-r contract Art. 4.3. 1 st Art. 4.2. 1 st t applicable evaluation and their replies indent the 65. R after contract signature or cancellation the Yes t applicable t applicable Yes (PPD and CCI) 66. Evaluation report a n-r contract the Art. 4.3. 1 st t applicable 67. R after contract signature or cancellation the Yes t applicable t applicable Yes (PPD and CCI) 68. 1.5. Award and signature contract or cancellation 69. Award decision n-r adoption the decision Art. 4.3. 1 st t applicable a For tenderers, a degree privileged access right is provided for in Article 113(2) the Financial Rules applicable to the general budget the Union (Regulation (EU, EURATOM) 966/2012 the European Parliament and the Council), which are applicable to the EMA as per Article 85.1 the EMA s Financial Regulation applicable to the budget EMA adopted by the Management Board on 15 January 2014. Those requests are therefore not dealt with under the provisions the Regulation (EC) 1049/2001 on Access to Documents, but under the relevant provisions the Financial Regulation. EMA/127362/2006 Page 10/15

70. R after adoption the decision Yes t applicable t applicable Yes 71. tification contract award to the successful n-r contract Art. 4.3. 1 st t applicable tenderer the 72. R after contract signature or cancellation the Yes t applicable t applicable Yes (PPD and CCI) 73. Contract and its annexes Yes n-r contract the Art. 4.3. 1 st 4.2. 1 st indent t applicable 74. R after contract signature or cancellation the Yes t applicable t applicable Yes (PPD and CCI) 75. tifications contract award to unsuccessful n-r contract Art. 4.3. 1 st t applicable tenderer the 76. R after contract signature or cancellation the Yes t applicable t applicable Yes (PPD and CCI) EMA/127362/2006 Page 11/15

77. Decision to cancel the R from signature the decision and information to the tenderers b Yes t applicable t applicable 78. tification to tenderers cancellation R from the notification to Yes t applicable t applicable Yes (PPD) tenderers having been made 79. Award cancellation notice Published on EMA website Yes t applicable t applicable 80. 2. Conflict interest declarations 81. Conflict interest declaration for staff - For EMA management: Yes t applicable t applicable current published on EMA website For all other EMA staff: R 82. Conflict interest declaration for staff - previous R Yes t applicable t applicable Yes (PPD) 83. Conflict interest declaration for experts - current Published on EMA website Yes t applicable t applicable b As soon as the decision is taken it must be communicated to tenderers. EMA/127362/2006 Page 12/15

84. Conflict interest declaration for experts - previous R Yes t applicable t applicable Yes (PPD) 85. Conflict interest declaration for Committee and Management Board Members - current Published on EMA website Yes t applicable t applicable 86. Conflict interest declaration for Committee and Management Board Members - previous R Yes t applicable t applicable Yes (PPD) 87. 3. SOPs and WINs 88. SOPs and WINs current version Published on EMA website Yes t applicable t applicable 89. SOPs and WINs previous versions R Yes t applicable t applicable 90. 4. Corporate s available on the EMA s website 91. Annual report Published on EMA website Yes t applicable t applicable 92. Work programme Published on EMA website Yes t applicable t applicable 93. Annual Budget Published on EMA website Yes t applicable t applicable EMA/127362/2006 Page 13/15

94. Report on budgetary and financial management Published on EMA website Yes t applicable t applicable 95. Annual accounts Published on EMA website Yes t applicable t applicable 96. European Court Auditors final report on the annual accounts the European Medicines Agency Published on EMA website Yes t applicable t applicable 97. Agendas and minutes the Management Board Published on EMA website Yes t applicable t applicable 1 2 Refers to any the EMA produces, receives or has in its possession. Means any natural or legal person, or any entity outside the EMA, including the Member States, other EU or non-eu Institutions and Bodies, and third countries. Either Yes or to be filled in. Yes may/shall lead to a consultation exercise with the third party (cfr. policy for further details) with a view to assessing whether an exception listed in Article 4 Regulation (EC) 1049/2011 is applicable, unless it is clear that the shall or shall not be disclosed. 3 Refers to classification in one the following categories: Releasable (R) or n-releasable (n-r). In certain situations the s are published on the EMA website. If this is the case, this will be indicated. 4 Either access to be granted (Yes) or to be refused (); in case third-party consultation the granting or not access will depend on the outcome such consultation. 5 Only to be filled in if access to EMA s is refused by virtue application one the exceptions mentioned in Article 4 Regulation (EC) 1049/2001, i.e. by referring to: Article 4.1.(a) The Agency shall refuse access to a where disclosure would undermine the protection the public interest as regards public security, defence and military matters, international relations, the financial, monetary or economic policy the EU or a Member State. Article 4.1.(b) The Agency shall refuse access to a where disclosure would undermine the protection privacy and the integrity the individual, in particular in accordance with EU legislation regarding the protection personal data. EMA/127362/2006 Page 14/15

Article 4.2. 1 st indent The Agency shall refuse access to a where disclosure would undermine the protection commercial interests a natural or legal person, including intellectual property. Article 4.2. 2 nd indent The Agency shall refuse access to a where disclosure would undermine the protection court proceedings and legal advice. Article 4.2. 3 rd indent The Agency shall refuse access to a where disclosure would undermine the protection the purpose inspections, investigations and audits. Article 4.3. 1st paragraph process. Access to a, produced, received or in possession the Agency shall be refused if disclosure the would seriously undermine the decision-making Article 4.3. 2nd paragraph Access to a containing opinions for internal use as part deliberations and preliminary consultations within the Agency shall be refused even after the decision has been taken if disclosure the would seriously undermine the Agency s decision-making process. 6 7 Additional justification to be provided in order to further elaborate on the rationale for not providing access as per the reference to the exceptions mentioned in Article 4. Redaction EMA s will be carried out to remove any reference to commercial confidential information or to personal data. EMA/127362/2006 Page 15/15